In a world shaped by biotechnology, why are so few college students exposed to its possibilities early on in their education?

PDS Biotechnology Corp (NASDAQ:PDSB) initiated the versatile 003 phase 3 clinical trial for Versamune HPV plus pembrolizumab, targeting HPV 16 positive head and neck cancer. The trial design ...

Natural products are among the most promising candidates for the development of new drugs. However, due to their structural complexity, they are often difficult to access.

Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...

Muscimol, a GABA-A (GABAA) receptor agonist, enhances GABA's inhibitory effect on neuronal activity by activating GABAA ...

WASHINGTON — The House Budget Committee advanced President Donald Trump’s multitrillion-dollar domestic policy package Sunday night, two days after a group of conservatives voted to reject it ...

A head-to-head trial found that tirzepatide led to significantly greater weight loss and waist reduction than semaglutide in ...

University of Dundee scientists have discovered a new target that could herald the development of new drugs to treat ...

The company's colorful logo has been a staple for decades, letting customers and online visitors know they're engaging with one of the company's products or services. The company rolled out new ...

Alamos et al. show that Agrobacterium engages in density-dependent interactions that dictate transformation efficiency and transgene expression. These findings enable a quantitative model to ...

Mississippi still hugs the bottom as the 48th best state, according to the 2025 U.S. News and World Report “Best States” rankings. The state has come in 48th or worse since U.S. News started ...

This title is part of a longer publication history. The full run of this journal will be searched. TITLE HISTORY A title history is the publication history of a journal and includes a listing of the ...